Slides
Page 1
Sumitomo Chemical India Limited Investor Presentation - September 2026 A YEAR OF STABILITY
Page 2
Innovate Nurture Grow SCIL Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sumitomo Chemical India Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment what so ever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party statements and projections. 2
Page 3
Financial Performance & Key Highlights
Page 4
Innovate Nurture Grow SCIL Performance Highlights – Quarter 930 907 Q2FY26 Q2FY27 -2% Revenue (Rs Crs) EBITDA (Rs. Crs) & EBITDA Margin (%) PAT (Rs Crs) PAT Margin (%) Gross Profit (Rs. Crs) & Gross Profit Margin (%) 401 369 43.1% Q2FY26 40.7% Q2FY27 -8% 218 186 23.4% Q2FY26 20.5% Q2FY27 -15% 178 157 19.1% Q2FY26 17.3% Q2FY27 -11% Given the seasonality in the business, it is best monitored on an annual basis 910.4 1121.7 903.5 988.3 929.8 907.3 39.0% 37.9% 38.4% 42.6% 43.1% 40.7% 23.6% 24.8% 20.8% 24.8% 23.4% 20.5% 16.9% 18.0% 15.9% 19.5% 19.1% 17.3% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% 0.0 200.0 400.0 600.0 800.0 1000.0 1200.0 Q2FY22 Q2FY23 Q2FY24 Q2FY25 Q2FY26 Q2FY27 Gross Profit Margin % EBITDA Margin % PAT Margin % Revenue (Rs. In crores) Historical Q2 Performance Trend 4
Page 5
Innovate Nurture Grow SCIL Performance Highlights – H1FY27 1,987 1,971 H1FY26 H1FY27 -1% Revenue (Rs Crs) EBITDA (Rs. Crs) & EBITDA Margin (%) PAT (Rs Crs) & PAT Margin (%) Gross Profit (Rs. Crs) & Gross Profit Margin (%) 803 786 40.4% H1FY26 39.9% H1FY27 -2% 437 419 22.0% H1FY26 21.3% H1FY27 -4% 356 372 17.9% H1FY26 18.9% H1FY27* +5% *Q1FY27 includes an Exceptional Item of Rs. 26.9 crore, representing the insurance claim received towards business interruption arising from the fire incident at the Company's Bhavnagar plant during FY23. Given the seasonality in the business, it is best monitored on an annual basis 1,692.4 2,106.4 1,627.7 1,827.2 1,986.6 1,970.7 37.7% 36.6% 35.1% 40.9% 40.4% 39.9% 21.5% 22.1% 16.5% 22.2% 22.0% 21.3% 15.4% 16.1% 12.6% 17.5% 17.9% 18.9% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% 0.0 500.0 1000.0 1500.0 2000.0 2500.0 H1FY22 H1FY23 H1FY24 H1FY25 H1FY26 H1FY27 Gross Profit Margin % EBITDA Margin % PAT Margin % Historical Half-yearly Performance Trend 5 Revenue (Rs. In crores)
Page 6
Innovate Nurture Grow SCIL Performance Highlights – Q2 & H1 FY27 ✓ The Indian agrochemical industry faced a challenging operating environment during H1FY27, with delayed monsoon onset, prolonged dry spells and a 13% rainfall deficit impacting crop sowing and agrochemical consumption. Weak seasonal demand affected offtake across key product categories, particularly insecticides, herbicides and fungicides. ✓ SCIL reported revenue of Rs. 907 crore in Q2FY27, down 2% YoY , and Rs. 1,971 crore in H1FY27, down 1%. H1 sales were impacted by lower volumes, partly offset by improved pricing following price increases undertaken during March to June 2026. Q2FY27 witnessed largely stable selling prices; however, sales volumes declined by a high-single-digit percentage, while margins were impacted by the absorption of higher-cost inventory procured during April – June 2026. ✓ Domestic business remained relatively resilient, while exports faced near-term pressure. Q2 domestic revenue grew 2% YoY to Rs. 774 crore, whereas exports declined 23% to Rs. 127 crore. Growth in Metal Phosphides and AND & EHD partially offset weakness across other product categories during H1FY27. ✓ Profitability reflected the timing of inventory cost absorption. Q1FY27 margins had benefited from the consumption of lower-cost opening inventory, while higher- cost inventory procured during Q1 flowed through the cost of sales in Q2FY27, temporarily impacting margins. Consequently, Q2 gross margin declined 240 bps YoY to 40.7% and EBITDA margin contracted 297 bps to 20.5%. However, on a cumulative H1FY27 basis, the margin profile remained broadly comparable to historical levels. ✓ The inventory-cost mismatch substantially normalised by the end of Q2, as procurement costs and selling prices aligned with prevailing market levels. ✓ The Company strengthened its product portfolio with the launch of Topgrain (biostimulant), the first global launch of a promising product developed by its affiliate, Sumitomo Bio-rational Company, USA, and Helibex during Q2FY27. Focused initiatives across key products supported growth in select high-priority molecules. Capital expenditure is progressing as planned, with production expected to commence within previously communicated timelines. ✓ H2FY27 is expected to remain challenging amid lower reservoir levels, the extended El Nino impact and potential constraints on crop acreages. ✓ SCIL remains focused on navigating near-term challenges through disciplined execution, differentiated products, targeted deployment of resources and dynamic pricing in response to evolving market conditions. Continued focus on key driver products is expected to support near-term performance amid uncertain demand conditions while advancing the Company's medium-term growth objectives. 6
Page 7
Innovate Nurture Grow SCIL District Rainfall Map from June 1 to September 30, 2026 7 Source: India Meteorological Department
Page 8
Innovate Nurture Grow SCIL Organization Chart (wef 1st September 2026) Kunal Mittal, Executive Vice President Dr. Suresh Ramachandran, Managing Director Board of Directors Dr. Suresh Ramachandran, Managing Director R&D, Product Development, Regulatory & Intellectual Property Sales & Marketing (All current segments) HR, Secretarial & Legal Compliances Business Development (new segments) Planning & Coordination Office Finance and Information Technology Business Planning, Procurement & Logistics Manufacturing, Responsible Care and Projects Hajime Shinomiya, Senior Vice PresidentFumio Suzuki, Senior Vice President Each of the above functions are led by Vice Presidents and General Managers having considerable experience; Most of the functional leaders have spent several years with the company and supported by a team of young & energetic professionals 8
Page 9
Innovate Nurture Grow SCIL Good to Great: The Five Pillars of SCIL’s Transformation 9
Page 10
Innovate Nurture Grow SCIL New Product Launches 10
Page 11
Innovate Nurture Grow SCIL Topgrain Product Launch Event 11
Page 12
Innovate Nurture Grow SCIL Helibex Product Launch Event 12
Page 13
Innovate Nurture Grow SCIL Excalia Max – An Integrated 360°DigitalCampaign 13
Page 14
Innovate Nurture Grow SCIL TopGrain – AI Content Across Platforms ChatGPT GeminiCopilotGoogle AI 14
Page 15
Innovate Nurture Grow SCIL Key Highlights ✓ Sumi Manthan, the Annual Conference of SCIL, was held in April 2026 at Delhi with attendance of 700+ commercial team members. ✓ The three-day event fostered a strong spirit of collaboration, learning, and shared experiences. ✓ The annual theme, "Collaborate to Conquer", aptly reflected SCIL's core strength and was a central highlight of the conference. The agenda featured insightful presentations reviewing the past year’s performance and outlining strategic priorities and new initiatives for 2026–27. ✓ As we move forward, the key takeaway from Sumi Manthan is to translate the spirit of "Collaborate to Conquer" into action at the ground level, ensuring that this philosophy is reflected in our everyday efforts and drives sustained success. Sumi Manthan 2026: Collaborate to Conquer for a Stronger Tomorrow 15
Page 16
Innovate Nurture Grow SCIL Redefining Creativity with GenAI: Sumi Max Wins at ad:tech India New Delhi Sumitomo Chemical India Limited was honored with the GenAI -Led Creative Award at the prestigious ad:tech India New Delhi for the digital campaign of our flagship brand, Sumi Max. 16
Page 17
Innovate Nurture Grow SCIL Key Launches across FY23 to FY25 17
Page 18
Innovate Nurture Grow SCIL FY25-26 Launches 18
Page 19
Innovate Nurture Grow SCIL #Q1FY27 includes an Exceptional Item of Rs. 26.9 crore, representing the insurance claim received towards business interruption arising from the fire incident at the Company's Bhavnagar plant during FY23. Given the seasonality in the business, it is best monitored on an annual basis Consolidated Profit & Loss Account Statement Particulars (Rs. Crs) Q2FY27 Q2FY26 YoY Q1FY27 QoQ H1FY27 H1FY26 YoY Revenue from Operations 907.3 929.8 -2% 1,063.3 -15% 1,970.7 1,986.6 -1% COGS 538.2 529.2 646.6 1,184.9 1,183.7 Gross Profit 369.1 400.6 -8% 416.7 -11% 785.8 802.9 -2% Gross Profit % 40.7% 43.1% -240 bps 39.2% 149 bps 39.9% 40.4% -54 bps Employee Expenses 70.2 69.5 73.2 143.4 140.3 Other Operating Expenses 113.1 113.0 110.2 223.3 225.4 Operating EBITDA 185.8 218.0 -15% 233.3 -20% 419.1 437.2 -4% EBITDA Margin 20.5% 23.4% -297 bps 21.9% -146 bps 21.3% 22.0% -74 bps Other Income 43.6 38.8 47.3 90.9 77.6 Depreciation 17.3 16.8 17.2 34.5 32.5 EBIT 212.1 240.1 -12% 263.3 -19% 475.4 482.3 -1% EBIT Margin 23.4% 25.8% -244 bps 24.8% -139 bps 24.1% 24.3% -15 bps Interest 1.9 2.2 2.0 3.9 3.9 Exceptional Items 0.0 0.0 -26.9# -26.9# 0.0 Profit Before Tax 210.2 237.8 -12% 288.2 -27% 498.4 478.4 4% PBT Margin 23.2% 25.6% -242 bps 27.1% -394 bps 25.3% 24.1% 121 bps Tax 52.8 60.1 73.7 126.5 122.6 Net Profit 157.4 177.8 -11% 214.5 -27% 371.9 355.9 5% Net Profit Margin 17.3% 19.1% -177 bps 20.2% -283 bps 18.9% 17.9% 96 bps Other Comprehensive Income 0.9 1.4 -1.0 -0.1 0.1 Total Comprehensive income for the period 158.3 179.2 -12% 213.5 -26% 371.8 355.9 4% 19
Page 20
Innovate Nurture Grow SCIL Consolidated Balance Sheet Cash, Cash Equivalents & Liquid Investments of ~Rs. 2,523 Crs as on 30th September 2026 Assets (Rs. Crs) Sep-26 Mar-26 Non-Current Assets (A) 1,516.9 1,134.0 Property, Plant and Equipment 420.4 437.3 Capital work-in-progress 20.7 2.5 Right to use an Asset 63.2 71.4 Goodwill 60.4 60.4 Other Intangible Assets 9.6 7.6 Intangible Assets under Development 14.6 17.2 Non-Current Financial Assets (i) Investments 486.7 265.5 (ii) Loans & other financial assets 411.5 236.8 Deferred tax Asset (net) 1.2 0.4 Non-Current tax Assets (net) 25.8 25.7 Other non-current Assets 2.8 9.1 Current Assets (B) 3,462.6 3,340.2 Inventories 747.1 766.1 Current Financial Assets (i) Investments 872.7 887.2 (ii) Trade receivables 886.9 735.6 (iii) Cash and cash equivalents 52.1 68.9 (iv) Bank balances other than (iii) above 2.0 51.8 (v) Loans 355.8 340.9 (vi) Other financial assets 436.1 343.4 Other Current Assets 109.9 146.3 Total Assets (A+B) 4,979.5 4,474.2 Equity & Liabilities (Rs. Crs) Sep-26 Mar-26 EQUITY (A) 3,700.7 3,393.8 Equity Share Capital 499.1 499.1 Other Equity 3,197.6 2,890.5 Non-controlling Interests 4.0 4.1 Non-Current liabilities (B) 89.6 110.6 Non-current Financial liabilities (i) Borrowings 1.2 1.3 Lease Liabilities 25.3 40.4 Provisions 37.0 40.9 Deferred tax liabilities (net) 26.0 27.9 Non-current Tax Liabilities 0.0 0.0 Current liabilities (C) 1,189.2 969.8 Current Financial liabilities (i) Borrowings 0.2 0.2 (ii) Trade Payables 450.5 397.1 (iii) Lease Liabilities 29.0 21.4 (iii) Other financial liabilities 566.5 454.7 Other current liabilities 80.9 69.2 Provisions 7.7 12.9 Current tax liabilities 54.4 14.3 Total Equity & Liabilities (A+B+C) 4,979.5 4,474.2 20
Page 21
Innovate Nurture Grow SCIL 85% 4% 3% 4% 2% 1% 1% 0% Revenue Breakup – H1FY27 39% 26% 9% 8% 9% 9% Insecticides Herbicides PGR Metal Phosphides Fungicides AND & EHD* 38% 25% 9% 9% 8% 11% H1FY26 H1FY27 Product Breakup Geographic Breakup Segment Breakup Bulk & Branded 30% 28% 70% 72% H1FY26 H1FY27 Generic Speciality 80% 79% 20% 21% H1FY26 H1FY27 Bulk Branded Domestic Exports 34% 41% 66% 59% H1FY26 H1FY27 * Animal Nutrition Division (AND) and Environmental Health Division (EHD) 85% 5% 3% 2% 3% 1% 1% 0% H1FY26 H1FY27 Domestic Africa Japan Asia (Ex. India) Europe South America North America Australia 21
Page 22
Innovate Nurture Grow SCIL Given the seasonality in the business, it is best monitored on an annual basis * No. of Days in period: Sep-26 – 92, Jun-26 – 91 days, Mar-26 – 365 days, Sep-25 – 92 days Particulars (Rs. Crs) Sep-26* Jun-26* Change (Sep-26 to Jun-26) Mar-26* Change (Sep-26 to Mar-26) Sep-25* Change (Sep-26 to Sep-25) Inventory (A) 747.1 883.6 -136.5 766.1 -19.0 613.3 133.8 Inventory Days (Inventories/ COGS* No. of days in period) (i) 115 124 149 95 Trade Receivables (B) 886.9 799.8 87.1 735.6 151.3 903.4 -16.5 Trade Receivables Days (Trade Receivables / Revenue*No. of days in period) (ii) 82 68 83 83 Trade Payables (C) 450.5 632.3 -181.8 397.1 53.4 483.8 -33.3 Trade Payables Days (Trade Payables/ COGS*No. of days in period) (iii) 70 89 77 75 Other Financial Liabilities (D) 566.5 553.3 13.2 454.7 111.8 525.4 41.1 Other Financial Liabilities Days (Other Current Liabilities / Revenue*No. of days in period) (iv) 53 47 51 48 Net Working Capital (A+B-C-D) 617.0 497.8 119.2 649.9 -32.9 507.5 109.5 Net Working Capital Days (i + ii – iii – iv) 76 56 103 55 Consolidated Working Capital Movement Key Highlights ✓ Net working capital days stood at 76 days as of September 2026, compared with 55 days in September 2025. Inventory days increased to 115 days from 95 days, primarily due to price increases and softer inventory liquidation during Q2FY27. The Company has initiated corrective measures to progressively normalise inventory levels during H2FY27. ✓ Cash & cash equivalent as on 30th September 2026 stood at Rs. 2,523 crore. Collections during H1FY27 amounted to approximately Rs. 2,231 crore, compared with Rs. 2,277 crore during H1FY26, reflecting continued focus on collections and receivables management. 22
Page 23
Innovate Nurture Grow SCIL Consolidated Cash Flow Statement Cash Flow Statement (Rs. Crs) Half Year ended 30-Sep-26 Half Year ended 30-Sep-25 Net Profit Before Tax 498.4 478.4 Adjustments for: Non-Cash Items / Other Investment or Financial Items -46.9 -26.5 Operating profit before working capital changes 451.5 452.0 Changes in working capital 84.5 55.6 Cash generated from Operations 536.0 507.6 Direct taxes paid (net of refund) 89.1 73.1 Net Cash from Operating Activities 446.8 434.5 Net Cash from Investing Activities -384.7 -359.9 Net Cash from Financing Activities -78.9 -72.0 Net Increase /(Decrease) in Cash and Cash equivalents -16.8 2.6 Add: Cash & Cash equivalents at the beginning of the period 68.9 38.2 Cash & Cash equivalents at the end of the period 52.1 40.9 23
Page 24
Innovate Nurture Grow SCIL Financial Performance TrendRevenue (Rs. In crores) 782.0 910.4 707.2 665.1 985.5 1121.7 753.7 651.6 724.2 903.5 542.0 674.2 838.9 988.3 641.9 679.4 1,056.8 929.8 568.0 683.7 1,063.3 907.3 36.1% 39.0% 37.6% 38.1% 35.1% 37.9% 35.3% 31.3% 31.1% 38.4% 39.8% 41.7% 38.9% 42.6% 42.1% 40.0% 38.1% 43.1% 47.4% 42.3% 39.2% 40.7% 19.2% 23.6% 17.9% 16.4% 19.1% 24.8% 16.0% 12.4% 11.1% 20.8% 12.1% 20.8% 19.2% 24.8% 16.5% 17.6% 20.7% 23.4% 17.5% 19.6% 21.9% 20.5% 13.5% 16.9% 12.6% 11.2% 14.0% 18.0% 12.0% 11.1% 8.5% 15.9% 10.1% 16.3% 15.1% 19.5% 13.6% 14.7% 16.9% 19.1% 13.3% 16.3% 20.2% 17.3% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% 50.0% 0.0 200.0 400.0 600.0 800.0 1000.0 1200.0 Gross Profit Margin % EBITDA Margin % PAT Margin % * One-time exceptional charge of Rs. 16.1 crore related to the impact of newly notified Labour Codes #Q1FY27 includes an Exceptional Item of Rs. 26.9 crore, representing the insurance claim received towards business interruption arising from the fire incident at the Company's Bhavnagar plant during FY23. 24
Page 25
Company Overview
Page 26
Innovate Nurture Grow SCIL Journey to 14x Growth in India SCIL – Vision & Mission Formidable Player in the Indian Agrochemicals Space Diversified & De-risked Portfolio Across the Agro-Chem Value Chain Strong Brand and Well-Entrenched Distribution Network Strategically Located Manufacturing Facilities Autonomous Board with Vast Industry Experience Strong Focus on R&D, Process Innovation and Safety, Health and Environment (SHE) Growth Strategies 26
Page 27
Innovate Nurture Grow SCIL SCIL - Vision & Mission Vision & Values Mission Vision: • To be a trusted market leader in Indian crop- protection sector • To develop a vibrant corporate culture • Endeavor to achieve success and sustainability through innovation & excellence Core Values: • Innovation • Excellence • Integrity • Respect & value all stakeholders • Customer focus • People focus • Sustainability Marketing and Sales: • Further penetration into Indian market & take leadership; expand exports • Strengthen Sales Force, Distribution and Product Portfolio Manufacturing: • Supplying the most competitive products with safe and stable operation and meet demand • Strengthen Procurement Power • Expand Manufacturing Functions Management & Support: • Establishing the most efficient organization to support business growth and alignment with SCC • Develop administrative efficiency while ensuring internal controls • Full & Strict Compliances • Value Creation for all stakeholders 27
Page 28
Innovate Nurture Grow SCIL Setting-up new organization, control system, PCO function and innovative sales team Exploration Phase : 2000 – 2009 SCIL incorporated in India as EHD (HHI) distribution company 2000 Manufacturing JV with New Chemi Industries 2001 Started ASD business 2002 Started EHD (Public Health) business 2003 Acquired product - ‘Sulfosulfuron’ Leader rights from Monsanto Acquired EHD (HHI) unit from Bayer Vapi 2005 2009 2006 Aggressive Growth Phase : 2010 – 2026 Revenue (Rs. Bn) 2010 : Acquisition of New Chemi Industries and integration with SCIL 2016 : Majority stake acquisition of Excel Crop Care Limited (ECC) Robust 14 times growth driven by Organic & In-organic expansion Started Animal Nutrition SCIL Sales ~ INR 2 Bn Feasibility study to set-up correct business model to capture potential in Indian market and start aggressive growth phase Journey to 14x Growth in India in last 15 years 4.5 4.9 6.5 7.1 7.9 8.5 9.0 10.0 24.2 26.4 30.6 35.1 28.4 31.5 32.4 7.2 6.9 7.8 9.8 10.3 9.0 9.7 11.9 13.2 2.3 FY10-11 FY11-12 FY12-13 FY13-14 FY14-15 FY15-16 FY16-17 FY17-18 FY18-19 FY19-20 FY20-21 FY21-22 FY22-23 FY23-24 FY24-25 FY25-26 ECC SCIL 9.5 11.4 12.7 16.3 17.4 16.9 18.2 19.1 22.3 Highest revenue Sector related temporary headwinds impacted revenues Highest profitability despite challenging environment SCIL 2.0 – 1st full year of integrated operations 28
Page 29
Innovate Nurture Grow SCIL Formidable Player in the Indian Agrochemicals Space Grown 14x+ over FY11-26 2.3 32.4 FY11 FY26 14x 5 Manufacturing Facilities 200+ Brands 700+ SKUs 14 Technical Actives 25+ Patents 200+ Registrations 15,000+ Direct Distributors & 60 Depots Rs. Bn Key Products Product Name Product Category Indicative Use Fenpropathrin Glyphosate Insecticide Herbicide Paddy, Cotton, F&V Tea Gardens, non-cropped Profenophos Pyriproxyfen Insecticide Insecticide Cotton, Soya bean Cotton Clothianidin Insecticides Vegetables Tebuconazole Fungicides Wheat, Soya bean, Chilli Gibberallic Acid Plant Growth Regulator Citrus Fruits Aluminum Phosphide Fumigant Warehousing of Food Grains Chlorpyriphos Insecticide Paddy, Beans, Gram DL-Methionine Animal Nutrition Poultry 1600+ Employees 1500+ FDOs# #FDOs - Field Development Officers (contractual) 29
Page 30
Innovate Nurture Grow SCIL Domestic 79% Exports 21% 27% 20% 16% 6% 27% 4%0% Australia North America South America Europe Asia (Ex. India) Japan Africa Diversified & De-risked Portfolio Across the Agro-Chem Value Chain 24% 8% 41% 9% 10% 8%Insecticides Herbicides PGR Metal Phosphides Fungicides AND & EHD ✓ Greater focus on high growth, stable and high profitable segments such as Herbicides, PGR, Bio-rational products ✓ Increasing contribution from PGR segment and offerings for both Kharif and Rabi crops to reduce seasonality in the business ✓ One of the highest proportion of environmentally-friendly products in the Industry FY26 Geographic Diversification with Exports to ~50 countries FY26 ✓ Top 10 products contributes less than 45% of Total Revenue on annual basis ✓ No product / molecule contributes more than ~17% of Total Revenue on annual basis ✓ Diversified across key crops - Concentrated efforts on fruits & vegetables, paddy, cotton and other high growth segments Well-Diversified across multiple dimensions Products Geographies Customers Crops ServedBusiness Segments 71% 29% Generics Speciality Diversified Portfolio Across Segments 30
Page 31
Innovate Nurture Grow SCIL 19% 81% Bulk Branded 60% 40% ✓ Strong brand with market leading position across various product categories ✓ Dual brand portfolio can offer products at all price points serving multiple customer sub-segmentsa ✓ In-depth knowledge of own research products, proven go-to-market strategy and deep farmer connect facilitates launch of Speciality products ✓ On-field demonstration of products, training of farmers in using the products, building awareness among stakeholders in relation to the products ✓ Pan-India distribution network ensures strong presence with both retailers and farmers and on-time feedback mechanism ✓ Scale and diversity of product offerings lead to superior bargaining power with distributors and provides one-stop solution for farmers 26 States 60 Depots 15,000+ Distributors ~40,000 Dealers 4.4 million+ Farmer Connect through physical meetings 20 million+ Digital Connect ~600 Sales Team Strong Brand and Well-Entrenched Distribution Network Bulk & Branded Contribution (FY26) Domestic Exports ✓ Expanded teams for strategic marketing, demand generation, product development and regulatory affairs to focus on future growth 31
Page 32
Innovate Nurture Grow SCIL Expanding Brand Visibility and Connect ✓ Wide range of generics and speciality products for Increased crop presence and providing crop protection solutions ✓ More than 1,500+ Relationship managers connecting to 4.4 million+ farmers throughout crop cycle ✓ Over 200 brands covering maximum of crops and pest segments ✓ 15,000+ distributors; 40,000+ dealers and 60 Depots help in expanding brand visibility and connect ✓ More than 600+ Qualified and skilled managers in Sales, Marketing and customer support ✓ Company with 20+ mega brands with high brand recall ✓ Healthy geographical Brand coverage throughout India including North East and J&K ✓ Optimum use of advertising media with increased Digital Platforms presence 32
Page 33
Innovate Nurture Grow SCIL Resurging Through Phygital Transformation (1/2) Rural India: Digitally Connected, Strategically Engaged With rural India witnessing a digital revolution—boasting over 442 million internet users and 425 million smartphone owners—SCIL has strategically positioned itself to lead this wave. Our data-driven digital marketing framework now serves as a powerful catalyst for business growth and rural community engagement. ✓ 814+ localized landing pages across key dialects, optimized for voice search and rural accessibility ✓ 639 precision-targeted digital campaigns mapped to crop cycles, geographies, and farmer needs ✓ 14.2 crore digital touchpoints, contributing significantly to lead generation, brand affinity, and dealer inquiries ✓ 17.2% reduction in engagement costs, driven by smart segmentation and programmatic delivery ✓ Partnerships with hyper- local influencers, enhancing message authenticity ✓ Field activity tracking Apps- Sumitomo Connect & Sumitomo Field Connect The Power of Phygital Field Days Our Field Days evolved into immersive Phygital experiences—where digital interactivity met on-ground demonstration. A standout initiative was the “Live Field Days”, allowing farmers, distributors, and field executives to engage in real-time with our agronomists, R&D experts, Portfolio Managers, Demand Generation and Sales teams. These live sessions: ✓ Enhanced farmer trust through live Q&A and transparent product demonstrations ✓ Drew strong participation from farmers, channel partners, and field teams across regions, fostering vibrant two-way engagement during each session 33
Page 34
Innovate Nurture Grow SCIL Resurging Through Phygital Transformation (2/2) Glimpses of “Live Field Days” 34
Page 35
Innovate Nurture Grow SCIL • Overall Optimal capacity utilization ~ 80% to 90% for TGAI’s • Bought 2 additional private owned land parcels for future expansion: o ~20 acre adjoining our existing Bhavnagar site o ~50 acre at a prime location at Dahej within Chemical Zone (recently received environmental clearance) Gujarat Maharashtra 4 Branches & 60 Depots Pan India Mumbai – Head Office 5 Manufacturing Plants Tarapur Vapi Bhavnagar Silvassa Gajod Connectivity to Major Cities and Proximity to Main Highways, Ports Reduces Logistic Time and Costs Dahej Mumbai Plant Location Area (acres) Segment Served Product Manufactured Bhavnagar ~58 Manufacturing of Technical Grade Pesticides and Formulations Technical Grade Products: Chlorpyriphos, Profenophos, Glyphosate, Tebuconazole Tech, Quinalphos, Imidacloprid, Thiacloprid, Acetamiprid, Byspyribac Sodium, Fluroxypyr, Aluminium Phosphide, Zinc Phosphide, Sulphur WDG, Fenpropathrin Formulations for above TG products and several other speciality and generic products Gajod ~120 Production and manufacturing of Metal Phosphides, Sulphur WDG and other WDG formulations Tarapur ~5 Production and manufacturing of Active Ingredients Vapi ~6 Formulation & Packaging Silvassa ~3 Formulation of Glyphosate and Other Speciality Products Strategically Located Manufacturing Facilities Mumbai Maps not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness 35
Page 36
Innovate Nurture Grow SCIL CAPEX Announced in January 2026 Additional Projects approved by the board of the company Plant for manufacturing Herbicide intermediate at Dahej site for supply to parent company • First strategic investment at the Dahej site, marking a key step in developing Dahej as a strategic global manufacturing hub for the parent company’s high - potential patented molecules . • Initial operations will commence using process know - how from the parent company, with SCIL driving further process optimization and cost efficiencies to enhance competitiveness and improve project payback metrics . • This is expected to be followed up with additional projects to enable future forward and backward integration, the same product as well as other high - potential patented molecules from the parent company’s pipeline . Capex budget: ~Rs 150 crore Fitment for additional products at Tarapur site for supply to parent company • The Company has also approved a capex for fitment to manufacture two additional molecules (one fungicide and one herbicide) at the existing Tarapur facility, primarily for supply to the parent company . • This investment leverages existing infrastructure, enhances asset utilisation and strengthens SCIL’s role as a strategic manufacturing hub within the parent group’s global supply chain . Payback period: Less than 5 years from start of operations Estimated Commercialization: Q2 FY2028-29 Capex budget: ~Rs 10 crore Estimated Commercialization: Q4 FY2027-28 36
Page 37
Innovate Nurture Grow SCIL ❑ 3 fully equipped, DSIR approved R&D labs located at Mumbai, Bhavnagar and Gajod capable of synthesis, technical product and formulation development; Soil Health Research Laboratory and in-house field trials ❑ R&D Team comprises of 75+ qualified and dedicated engineers & scientists of which 10+ are PhDs with more than 15 years of Experience ❑ 25+ patents granted across various geographies; 9 applications filed ❑ R&D facilities to gain capability for creating new processes and new combinations using SCC Japan’s chemistries which would help improve production processes and efficiency FORMULATION DEVELOPMENT Bhavnagar, Synthesis Lab Bhavnagar, R&D Analytical lab Bhavnagar, Soil Health Research Lab Bhavnagar, Biopesticides Unit R&D: End-to-End Product Development Capabilities 37
Page 38
Innovate Nurture Grow SCIL Dr. Vikram Sarabhai award for developing green technology from department of Science and Technology, Government of Gujarat Certificates of appreciation received ten times from jointly by Gujarat Safety Council and Dish Government of Gujarat for achieving 10 lakh accident free man-hours Certificates of merits received from jointly by Gujarat Safety Council and Dish Government of Gujarat for achieving 20 lakh accident free man-hours Certificates of honour received two times jointly by Gujarat Safety Council and Dish Government of Gujarat for achieving 30 lakh accident free man- hours Thrust on Safety, Health and Environment (SHE) ISO:9001:2015, ISO-14001:2015 and OHSAS18001:2007 for the manufacturing sites at Bhavnagar, Gajod, Tarapur and Silvassa; ISO:9001:2015 at Vapi A8000 Certification for Social Accountability in Bhavnagar and Gajod Efforts focused on reducing effluent load and effluent treatment cost, for staying innovative and competitive in the market The quality of the products is maintained and upgraded to the applicable national and international standards through rigorous pursuit of Six Sigma initiative Focused on energy conservation and energy cost reduction: 65% of total power requirement through wind and solar power generation plants Expanding solar power plant capacity in line with towards green energy would also help in reducing dependence on outsourced power as well as in energy cost reduction 3R Principle: Recovery – Recycle – Reuse Safety audit, training programmes and other safety management processes and programmes are carried out/conducted at regular intervals Abiding by SCC Japan’s EHS Policies Quality Certifications Ensure Consistent product quality and healthy working environment at manufacturing sites Focus on purity, quality and timely delivery of products to the customer Authorized Economic Operator AEO (Tier-2) Certification Four Start Export House by Ministry of Commerce and Industry 38
Page 39
Innovate Nurture Grow SCIL Awards & Accolades Jamnalal Bajaj Award for “Fair Business and Practices” Chemexcil Best Exporter's award: 2017-18 received in 2023 First award for export of organic and inorganic chemicals Quality Certifications Ensure Consistent product quality and healthy working environment at manufacturing sites Focus on purity, quality and timely delivery of products to the customer ICMA award for innovation and purposeful programs for social progress First Sir P .C. Ray award for development of products and process with indigenous technology Punjab Haryana Delhi Chamber of Commerce and Industries award for ethical business Winner active ingredient trophy and certificate from M/s. Bayer Trishul award for the excellent performance for exports in international markets Global CSR award from SCC for one of our Integrated Village Development Programme ICMA award for innovation and purposeful programs for social progress Shramveer award for improvement of product efficiency received from national level Delhi Vishwakarma Rashtriya Puraskar received for process development National Safety Award by Labour Ministry, Government of India for safety performance Shramveer Award to employees from Labour Ministry, state level received six times Shram Bhushan Award to employees received five times Shram Ratna to employees, received seven times Shram Shri award to employees received three times Gujarat State Safety Certificate for safety commitment CSR Award from Federation of Gujarat Industries 39
Page 40
Innovate Nurture Grow SCIL Autonomous Board with Vast Industry Experience Board is supported by a strong and experienced management team associated with Company since long Tadashi Katayama Non-executive Director ▪ MBA from Vanderbilt University, U.S.A. and a Master’s degree from Kyoto University in Japan ▪ Associated with SCC Japan since 1992 in the Health and Crop Science business unit in various positions President of Agro Life Sciences sector at SCC Japan Masanori Uzawa Non-executive Director ▪ MBA from University of Virginia, USA and a Bachelor’s degree from the University of Tokyo in Japan ▪ Associated with SCC Japan and has experience of over 21 years in the areas of strategy, planning and business development for crop protection & other chemical businesses. ▪ Head of Agro Solutions Division International Dr Suresh Ramachandran Managing Director ▪ Ph.D. in Entomology“ from The University of Georgia, USA ▪ 27 years of expertise - Sales and Distribution, Product Management, Regulatory, Business Management, R&D, Six Sigma & Enterprise Resource Planning, in Crop Protection & Seeds Business. Chetan Shantilal Shah Chairman and Non-executive Non-Independent Director ▪ Commerce graduate from the University of Mumbai and holds a master’s degree in Business Administration from North Rope University in the USA ▪ Over 46 years of industry experience in various leadership and senior management roles 40
Page 41
Innovate Nurture Grow SCIL Independent Board with Strong Governance Credentials Preeti Gautam Mehta Independent Non-executive Director ▪ 33 years of experience in corporate laws, foreign investment and collaborations, mergers and acquisitions and private equity investments, banking, franchising and hospitality N. Sivaraman Independent Non-executive Director ▪ Qualified Chartered Accountant with close to 41 years of experience as finance professional and business and organizational leader. ▪ He had over 35 years of successful career with Larson & Toubro Group holding position of President and Whole-time Director of L&T Finance Holdings Limited and board membership of L&T Infrastructure Finance Limited where he played pivotal role. Managing Director and Group CEO at ICRA Limited and COO of IL&FS Limited Anand Mohan Tiwari Independent Non-executive Director ▪ Over 30 years of distinguished experience in governance, public administration, energy, petrochemicals, fertilizers and social development through leadership roles in the Indian Administrative Service and major state enterprises. ▪ Extensive expertise in corporate leadership, rural development, education, skill development and CSR initiatives, supported by strong board-level experience and international exposure. 41
Page 42
Innovate Nurture Grow SCIL Growth Strategies Achieving Market Leadership in India ▪ Balanced portfolio of specialty products (including futuristic green products) and off- patent products ▪ Consolidate position as best agro-chemical marketer in India ▪ Strive for manufacturing excellence & expand Make in India Projects ▪ Making organization ready to handle future challenges (Transform) ▪ Sustainable and healthy financial results (Harvest) Leverage expertise in successful product launches, demand generation and manufacturing capacity expansions to fuel future growth Capacity Expansion • Driving operational efficiencies maintaining highest safety standards and Responsible Care compliances • Invest ~15% of consolidated EBITDA every year for upgradation of manufacturing facilities and capacity expansion to cater to strong domestic/global demand Continued Investment in R&D and Pipeline • Aim to invest in seamless integration of R&D between SCIL and SCC units which would help improve our production processes, enhancing yields and efficiency • Introduce new products as per market demand Further Brand Development • Investments for marketing of new and existing products and brands • On-field demonstrations, training of farmers for building ground-level demand generation supported by digital marketing • Extraordinary preparations for new product launches underway Expand Export Business • Enhance exports in regions like Africa Leverage SCC’s Global supply chain and marketing network to drive exports in Latin America, Asia and Europe Product Pipeline • Multiple products coming from initiatives • Global Speciality Proprietary products to be launched in India • New combination products / pre-mixtures currently under development for domestic and exports • Off-patent products under development for domestic and exports • Technical products for manufacturing and exports 42
Page 43
Financial Performance & Key Takeaways
Page 44
Innovate Nurture Grow SCIL *One-time exceptional charge of Rs. 16.1 crore related to the impact of newly notified Labour Codes ^ ROCE – {EBIT/ (Net Worth + Borrowings)} 2,645 3,065 3,511 2,844 3,149 3,238 FY21 FY22 FY23 FY24 FY25 FY26 +15% Revenue (Rs Crs) 345 424 502 370 506 543 FY21 FY22 FY23 FY24 FY25 FY26* +9% 1,541 1,927 2,382 2,445 2,905 3,394 FY21 FY22 FY23 FY24 FY25 FY26 +17% FY21 FY22 FY23 FY24 FY25 29.8% 30.2% 27.7% 20.8% 29.0% FY26 31.0% 104 133 124 91 89 103 FY21 FY22 FY23 FY24 FY25 FY26 EBITDA (Rs. Crs) & EBITDA Margin (%) PAT (Rs Crs) Networth (Rs Crs) RoCE (%)^ Net Working Capital Days Historical Performance Highlights 487 600 667 475 632 671 18.4% FY21 19.6% FY22 19.0% FY23 16.7% FY24 20.1% FY25 FY26 20.7% +7% +4% 44
Page 45
Innovate Nurture Grow SCIL *One-time exceptional charge of Rs. 16.1 crore related to the impact of newly notified Labour Codes Appointed date for merger of ECC and SCIL is 1st Apr’18 Consolidated Profit & Loss Account Statement Particulars (Rs. Crs) FY26 FY25 FY24 FY23 FY22 FY21 Net Revenue from Operations 3,238.3 3,148.5 2,843.9 3,511.0 3,061.2 2,644.9 COGS 1,877.4 1,858.9 1,775.1 2,270.6 1,908.0 1,655.4 Gross Profit 1,360.9 1,289.6 1,068.9 1,240.3 1,153.2 989.5 Gross Profit % 42.0% 41.0% 37.6% 35.3% 37.7% 37.4% Employee Expenses 273.8 264.7 232.0 218.4 202.0 194.3 Other Operating Expenses 416.3 392.9 362.3 355.4 351.3 308.4 Operating EBITDA 670.9 632.1 474.6 666.6 599.9 486.9 EBITDA Margin 20.7% 20.1% 16.7% 19.0% 19.6% 18.4% Other Income 146.7 120.1 95.7 44.9 26.8 18.6 Depreciation 66.1 66.1 62.2 51.9 44.8 46.6 EBIT 751.5 686.1 508.1 659.6 581.9 458.9 EBIT Margin 23.2% 21.8% 17.9% 18.8% 19.0% 17.3% Interest 7.8 5.9 5.1 5.4 6.2 5.6 Profit Before Tax & Exceptional 743.6 680.2 502.9 654.2 575.7 453.3 Exceptional Item Gain / (Loss) 16.1* - - - - - Profit Before Tax 727.6 680.2 502.9 654.2 575.7 453.3 PBT Margin 22.5% 21.6% 17.7% 18.6% 18.8% 17.1% Tax 184.6 173.8 133.2 152.0 152.2 107.9 Net Profit 543.0 506.4 369.7 502.2 423.5 345.4 Net Profit Margin 16.8% 16.1% 13.0% 14.3% 13.8% 13.1% Other Comprehensive Income 5.6 -1.0 -0.4 2.3 2.4 1.6 Total Comprehensive income for the period 548.6 505.5 369.4 504.5 425.9 347.0 EPS 10.88 10.13 7.40 10.06 8.49 6.9 45
Page 46
Innovate Nurture Grow SCIL Consolidated Balance Sheet Assets (Rs. Crs) Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Non-Current Assets (A) 1,134.0 944.1 640.4 581.2 487.6 367.6 Property, Plant and Equipment 437.3 425.8 451.7 392.8 349.6 277.6 Capital work-in-progress 2.5 9.4 4.0 53.5 21.1 4.3 Right to use an Asset 71.4 63.5 42.5 33.2 36.4 31.1 Goodwill 60.4 60.4 62.2 - - - Other Intangible Assets 7.6 6.7 6.0 3.8 4.3 0.6 Intangible Assets under Development 17.2 19.1 18.7 17.7 14.1 10.0 Non-Current Financial Assets (i) Investments 265.5 67.1 0.1 0.1 0.1 0.1 (ii) Loans & other financial assets 236.8 247.9 13.8 36.4 30.8 6.0 Deferred tax Asset (net) 0.4 1.2 0.7 - - - Non-Current tax Assets (net) 25.7 37.5 37.7 34.9 21.6 20.4 Other non-current Assets 9.1 5.7 2.8 8.7 9.5 17.6 Current Assets (B) 3,340.2 3,020.3 2,672.9 2,787.5 2,522.0 2,304.3 Inventories 766.1 703.7 610.4 888.7 937.8 754.4 Current Financial Assets (i) Investments 887.2 457.2 345.7 238.8 356.02 290.2 (ii) Trade receivables 735.6 783.4 715.9 946.1 843.13 848.2 (iii) Cash and cash equivalents 68.9 38.2 46.6 46.9 57.25 213.3 (iv) Bank balances other than (iii) above 51.8 4.6 136.7 256.0 21.88 28.8 (v) Loans 340.9 101.9 181.2 236.5 0.47 7.7 (vi) Other financial assets 343.4 814.5 536.5 48.5 174.50 11.4 Other Current Assets 146.3 116.9 99.8 126.1 131.03 150.3 Total Assets (A+B) 4,474.2 3,964.4 3,313.3 3,368.7 3,009.6 2,671.9 Equity & Liabilities (Rs. Crs) Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 EQUITY (A) 3,393.8 2,905.1 2,444.5 2,381.8 1,927.2 1,541.3 Equity Share Capital 499.1 499.1 499.1 499.1 499.1 499.1 Other Equity 2,890.5 2,402.0 1,942.4 1882.6 1428.1 1,042.2 Non-controlling Interests 4.1 3.9 3.0 0.0 0.0 0.1 Non-Current liabilities (B) 110.6 94.2 68.0 53.9 61.0 49.6 Non-current Financial liabilities (i) Borrowings 1.3 - - - - - Lease Liabilities 40.4 32.8 18.5 17.7 24.7 15.3 Provisions 40.9 34.8 25.9 22.6 22.3 29.2 Deferred tax liabilities (net) 27.9 26.6 23.6 13.6 13.9 5.0 Non-current Tax Liabilities 0.0 - - - - - Current liabilities (C) 969.8 965.2 800.7 933.0 1,021.4 1,081.0 Current Financial liabilities (i) Borrowings 0.2 0.0 0.5 - - - (ii) Trade Payables 397.1 489.4 430.0 490.2 517.2 591.2 (iii) Lease Liabilities 21.4 19.1 11.2 16.2 12.9 17.3 (iii) Other financial liabilities 454.7 377.3 294.8 366.2 399.7 356.8 Other current liabilities 69.2 64.4 53.2 51.2 79.8 108.2 Provisions 12.9 9.3 10.4 6.3 7.2 5.6 Current tax liabilities 14.3 5.6 0.5 2.8 4.7 1.9 Total Equity & Liabilities (A+B+C) 4,474.2 3,964.4 3,313.3 3,368.7 3,009.6 2,671.9 46
Page 47
Innovate Nurture Grow SCIL Particulars (Rs. Crs) Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Inventory (A) 766.1 703.7 610.4 888.7 937.8 754.4 Inventory Days (Inventories/ COGS*365) (i) 149 138 126 143 179 166 Trade Receivables (B) 735.6 783.4 715.9 946.1 843.1 848.2 Trade Receivables Days (Trade Receivables / Revenue*365) (ii) 83 91 92 98 100 117 Trade Payables (C) 397.1 489.4 430.0 490.6 517.2 598.3 Trade Payables Days (Trade Payables/ COGS*365) (iii) 77 96 88 79 99 132 Other Financial Liabilities (D) 454.7 377.3 294.8 366.2 399.7 349.8 Other Financial Liabilities Days (Other Current Liabilities / Revenue*365) (iv) 51 44 38 38 48 48 Net Working Capital (A+B-C-D) 649.9 620.3 601.5 978.0 864.0 654.5 Net Working Capital Days (i + ii – iii – iv) 103 89 91 124 133 103 Consolidated Working Capital Movement 47
Page 48
Innovate Nurture Grow SCIL Particulars (Rs. Crs) Year ended 31-Mar-26 Year ended 31-Mar-25 Year ended 31-Mar-24 Year ended 31-Mar-23 Year ended 31-Mar-22 Year ended 31-Mar-21 Net Profit Before Tax 727.6 680.2 502.9 654.2 575.7 453.3 Adjustments for: Non-Cash Items / Other Investment or Financial Items -51.3 -46.8 -6.7 38.5 46.3 54.5 Operating profit before working capital changes 676.2 633.4 496.3 692.7 622.0 507.8 Changes in working capital -66.9 -18.0 392.6 -135.2 -257.6 25.6 Cash generated from Operations 609.4 615.4 888.8 557.5 364.4 533.4 Direct taxes paid (net of refund) 163.8 163.9 129.0 168.1 142.6 107.9 Net Cash from Operating Activities 445.5 451.5 759.8 389.4 221.8 425.4 Net Cash from Investing Activities -332.0 -392.0 -431.7 -327.2 -290.2 -282.7 Net Cash from Financing Activities -82.9 -67.9 -328.3 -72.5 -62.6 -47.1 Net Increase /(Decrease) in Cash and Cash equivalents 30.7 -8.4 -0.3 -10.4 -131.1 95.7 Add: Cash & Cash equivalents at the beginning of the period 38.2 46.6 46.9 57.2 188.3 92.6 Cash & Cash equivalents at the end of the period 68.9 38.2 46.6 46.9 57.2 188.3 Consolidated Cash Flow Statement 48
Page 49
Innovate Nurture Grow SCIL Key Takeaways ▪ Strong / leadership position across products and processes ▪ Ability to develop new combination products ▪ Strong management and autonomous Board with vast experience and domain expertise ▪ Localized experience enables better understanding of market needs to drive growth ▪ Multi-product, multi-geography, multi-customer de-risking ▪ Access to an impressive range of own actives along with significant exposure towards speciality products resulting in product offerings at all price points serving multiple customers sub-segment ▪ 26 states, 60 depots, 15,000+ distributors, 40,000+ dealer network ▪ High credibility and brand recall amongst famers and the trade on account of transparent and ethical business dealings Formidable Player in the Indian Agro-chem Space Experienced Management Team and Board of Directors Well-diversified Product Portfolio Across Agro-Chem Value Chain Strong Brand and Well-Entrenched Distribution Network ▪ Benefits from international standing of SCC Japan; most well revered brand renowned for its quality ▪ Access to SCC’s global supply chain and global R&D activities (one of the largest spenders) resulting in development of actives and broad range of formulation research To Benefit from Strong Parentage of SCC Japan ▪ Operates five manufacturing facilities with state-of-the-art plants at strategic location which helps reduce logistic time and costs ▪ Capacity not a constraint allowing for significant growth on existing investments State-of-the-art Manufacturing and R&D Facilities ▪ Grown 14X over FY11-26 driven by organic and inorganic expansion ▪ Debt free balance sheet with strong return ratios Strong Track Record of Driving Growth 49
Page 50
Annexures Glance of various events to bring people together
Page 51
Innovate Nurture Grow SCIL 25 Years Celebration 51
Page 52
Innovate Nurture Grow SCIL 'Every Day Farmers’ Day' Campaign 52
Page 53
Innovate Nurture Grow SCIL 'Every Day Farmers’ Day' Campaign ONE TEAM...ONE MISSION... ONE CAMPAIGN 53
Page 54
Innovate Nurture Grow SCIL 'Every Day Farmers’ Day' Campaign 54
Page 55
Innovate Nurture Grow SCIL Demand Generation Activities via EDFD 55
Page 56
Innovate Nurture Grow SCIL Selected Retailer & Grower Launching Meetings 56
Page 57
Innovate Nurture Grow SCIL Prelaunch Activities 57
Page 58
Innovate Nurture Grow SCIL Glance of various events to bring people together Strategic Workshop of senior and middle management to deliberate on growth acceleration Logo for Annual Distributors meeting - Bandhan means strong bondingLogo for Annual Sales Team meeting - Manthan means joint efforts to squeeze out the results Logo showing Core Values 58
Page 59
For further information, please contact: jigar.kavaiya@sgapl.net parin.n@sgapl.net Company : Investor Relations Advisors : Sumitomo Chemical India Limited CIN: L24110MH2000PLC124224 investor .relations@sumichem.co.in Strategic Growth Advisors Pvt. Ltd. CIN: U74140MH2010PTC204285 Mr . Jigar Kavaiya / Mr . Parin Narichania +91 99206 02034 / +91 99300 25733 jigar .kavaiya@sgapl.net / parin.n@sgapl.net www.sgapl.net www.sumichem.co.in For further information, kindly visit our new website www.sumichem.co.in